Palovarotene
| CAS No. | 410528-02-8 |
|---|---|
| MDL No. | MFCD10565968 |
| MF | C27H30N2O2 |
| MW | 414.50 |
| InChI Key | YTFHCXIPDIHOIA-DHZHZOJOSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Palovarotene is an olefinic compound with a 4-carboxyphenyl group at position 1 and a 5,5,8,8-tetramethyl-3-[(1H-pyrazol-1-yl)methyl]-5,6,7,8-tetrahydronaphthalen-2-yl group at position 2 (the E-stereoisomer). It is a selective RARgamma agonist developed by Ipsen to reduce new heterotopic ossification in adults and children with fibrodysplasia ossificans progressiva (FOP). It functions as a retinoic acid receptor gamma agonist and belongs to the classes of stilbenoids, tetralins, pyrazoles, benzoic acids, and olefinic compounds.
| CAS No. | 410528-02-8 |
|---|---|
| Product Name | Palovarotene |
Biological Targets
RARG
Associated Conditions
dry eye syndrome·fibrodysplasia ossificans progressiva
* The information provided here is compiled from public sources and is for reference only.